China Health Industries Holdings (China Health Industries Holdings) GF Value : $0.01 (As of May. 11, 2024)

View and export this data going back to 2006. Start your Free Trial

What is China Health Industries Holdings GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-11), China Health Industries Holdings's share price is $2.05. China Health Industries Holdings's GF Value is $0.01. Therefore, China Health Industries Holdings's Price-to-GF-Value for today is 205.00.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes China Health Industries Holdings is Significantly Overvalued.

China Health Industries Holdings (OTCPK:CHHE) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

China Health Industries Holdings's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	2.05	/	0.01
	=	205.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Industries Holdings GF Value Related Terms

Thank you for viewing the detailed overview of China Health Industries Holdings's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Industries Holdings (China Health Industries Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Health Industries Holdings Inc (OTCPK:CHHE) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028

Website

http://www.chinahealthindustries.com

China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.

Executives

Sun Xin	director, 10 percent owner, officer: CEO, CFO and Treasurer	NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000
Hall E Ewing	director, officer: Secretary	2737 W BASELINE RD 22, TEMPE AZ 85283
Jack C Robinson	director	16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297
Teri S Foster	director	402 CANDOVER COURT, KATY TX 77450
Brian Lee Hahn	director, officer: COO	422 LAMONT TERRACE, BUFFALO GROVE IL 60089
Dennis Mckee	10 percent owner	3522 DOHERTY PLACE, KATY TX 77449
Thomas Allen Bontems	10 percent owner, officer: President, CEO, CFO and, other: Secretary	1808 S. 1ST AVENUE, PHONEIX AZ 85003

China Health Industries Holdings (China Health Industries Holdings) Headlines

No Headlines